- SPONSORED
PD-1/PD-L1 blockade-based combination therapies have shown potent antitumor effects but primary ...
New efforts seek to improve the efficacy of ICIs
- SPONSORED
Download this white paper for more information on CAR T-cell therapy.
A glimpse at how this tech is helping provide new insights into TME.
- SPONSORED
In these studies, recombinant cytokines of high purity and activity are indispensable for various ...
- SPONSORED
Recombinant cytokines have a great potential for cancer immunotherapy.
Exploiting the best of two worlds
- SPONSORED
Immunotherapy harnesses the ability of the immune system to fight cancer.
- SPONSORED
TIGIT is an emerging checkpoint inhibitor and blocking CD155:TIGIT interaction represents an ...
- SPONSORED
This webinar explores antibody discovery platforms and discusses how single b-cell sorting can be ...
- SPONSORED
This eBook investigate some of the most exciting research topics in this area, including targeting ...
- SPONSORED
Biochemical assays are complemented by quantitative cell-based reporter assays which provide ...
- SPONSORED
This application note summarizes recent tools developed for immune checkpoint therapeutic antibodies...
- SPONSORED
Study looks at the reactivity profiles and biophysical characteristics of monoclonal antibodies ...
- SPONSORED
Drug target research is crucial in mechanism-based drug discovery and development.
Despite some successes, CPIs are not magic bullets.
- SPONSORED
High-quality recombinant proteins are important starting materials for successful research efforts ...
Find out who coined the term vaccination and what Coley’s toxins were.
Turning foe into friend.
- SPONSORED
Oncology research encompasses many processes that have a role in cancer development and progression....
Frontiers in CPI analysis involve optimizing today's analytic paradigm.
Engineering an immune system–driven attack on cancer is getting easier.
Engineering an immune system–driven attack on cancer is getting easier.
New developments are extending the utility of flow.